PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 16, 2008 Subscribe to this News Feed    
 

Ricochet Public Relations to Host Mitchell Wong, Leading Patent Attorney, For Guest Lecture on Generic Pharmaceuticals

As Leading Brand Drugs Come Off Patent, Specialized Media Relations Firm Prepares For Industry Shift. Today Mitchell Wong, a biotech and pharmaceutical litigator at the New York office of Morrison & Foerster LLP, will guest lecture on the rise of generics in the pharmaceutical industry to junior associates enrolled in Ricochet's pioneering Publicist Certification ProgramTM.

New York, NY (PRWEB) November 16, 2008 -- Ricochet Public Relations Inc., a specialized media relations firm working in healthcare, technology, and industry, today announced Mitchell Wong, a biotech and pharmaceutical litigator at the New York office of Morrison & Foerster LLP, will guest lecture on the rise of generics in the pharmaceutical industry to junior associates enrolled in Ricochet's pioneering Publicist Certification ProgramTM.

Mr. Wong, admitted to the bar in New York, England and Wales, and Hong Kong, is a recognized leader within the bar and industry. With experience as a counselor and litigator on patent matters in fields ranging from pharmaceuticals to the technology industry, Mr. Wong's expertise provides a strong supplement to the Publicist Certification ProgramTM.

The Publicist Certification ProgramTM, a six month, in-house program of study, trains and educates associate members of Ricochet's account teams with the expertise and erudition of the most seasoned PR professionals. Ricochet is the only PR firm that requires all of its publicists to be experts in the field in which they work. The program strives to present and instruct junior members with the most up-to-date information and developments available. With the contribution of Mr. Wong's expertise, Ricochet will further arm its professionals with in-depth knowledge of the rise of generic drugs and the complex legal issues inherent in that industry.

"In the pharmaceutical industry, there is an increasing focus on drug patents, the introduction of generics and the lawsuits involved," said Todd Aydelotte, President, of Ricochet Public Relations. "At Ricochet, we want to keep our publicists educated on these developments so they can better understand their field and job at hand. We are happy to have Mr. Wong, with his unmatched background and first-hand insights into these multi-million dollar suits, helping to bolster our existing publicist education program."

Founded in 2000, Ricochet Pubic Relations has earned a strong reputation for growing companies through strategic PR programs. At the center of their portfolio of services lies their ability to generate sustained, intelligent press exposure for clients. Ricochet PR works in only three practice areas - healthcare, technology and industry - and requires every one of their publicists to be experts in the fields in which they work. To accomplish this, they created the Ricochet Publicist Certification Program™, the only program of its kind in the PR industry.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1FbXB0LUNyYXMtWmV0YS1UaGlyLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Michael Matkin
Ricochet Public Relations
(212) 679-3300
Email us Here
Mitchell M. Wong
Morrison & Foerster LLP
(212) 468-8063
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move